Cargando…

Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients

BACKGROUND: Tacrolimus is a narrow therapeutic index medication, which requires therapeutic drug monitoring to optimize dosing based on systemic exposure. MITRA microsampling offers a convenient, minimally invasive approach for the collection of capillary blood samples from a finger prick versus con...

Descripción completa

Detalles Bibliográficos
Autores principales: Undre, Nasrullah, Dawson, Ian, Aluvihare, Varuna, Kamar, Nassim, Saliba, Faouzi, Torpey, Nicholas, Anaokar, Swapneel, Kazeem, Gbenga, Hussain, Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115740/
https://www.ncbi.nlm.nih.gov/pubmed/33278240
http://dx.doi.org/10.1097/FTD.0000000000000847
_version_ 1783691252108099584
author Undre, Nasrullah
Dawson, Ian
Aluvihare, Varuna
Kamar, Nassim
Saliba, Faouzi
Torpey, Nicholas
Anaokar, Swapneel
Kazeem, Gbenga
Hussain, Imran
author_facet Undre, Nasrullah
Dawson, Ian
Aluvihare, Varuna
Kamar, Nassim
Saliba, Faouzi
Torpey, Nicholas
Anaokar, Swapneel
Kazeem, Gbenga
Hussain, Imran
author_sort Undre, Nasrullah
collection PubMed
description BACKGROUND: Tacrolimus is a narrow therapeutic index medication, which requires therapeutic drug monitoring to optimize dosing based on systemic exposure. MITRA microsampling offers a convenient, minimally invasive approach for the collection of capillary blood samples from a finger prick versus conventional venous blood sampling for quantitation of tacrolimus blood concentrations. However, the suitability of MITRA microsampling for the determination of tacrolimus concentrations requires assessment in clinical settings. METHODS: Paired venous (2 mL) and capillary (10 μL) blood samples were collected pre–tacrolimus dose and 1 and 3 hours postdose during routine outpatient visits from stable adult liver or kidney transplant patients receiving prolonged-release tacrolimus. Tacrolimus concentrations were determined by liquid chromatography–tandem mass spectrometry, and the concentrations obtained by the 2 sampling methods were compared by linear regression and Bland–Altman agreement analyses. RESULTS: Samples were available for 82 transplant recipients (kidney, n = 41; liver, n = 41). A high correlation was observed between tacrolimus concentrations in capillary and venous blood samples (Pearson correlation coefficient, 0.97; Lin concordance coefficient, 0.87; slope of the fitted line, >1.0). Tacrolimus concentrations in capillary samples were 22.5% higher on average than in the corresponding venous blood samples (95% limits of agreement, 0.5%–44.6%). Similar results were observed in both transplant subgroups. CONCLUSIONS: MITRA finger prick sampling provides a convenient alternative to venipuncture for therapeutic drug monitoring in transplant recipients maintained on prolonged-release tacrolimus. When using the finger prick MITRA method, the positive bias in tacrolimus concentrations observed with this technique, when compared with venipuncture, needs to be taken into consideration.
format Online
Article
Text
id pubmed-8115740
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Therapeutic Drug Monitoring
record_format MEDLINE/PubMed
spelling pubmed-81157402021-05-20 Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients Undre, Nasrullah Dawson, Ian Aluvihare, Varuna Kamar, Nassim Saliba, Faouzi Torpey, Nicholas Anaokar, Swapneel Kazeem, Gbenga Hussain, Imran Ther Drug Monit Focus Series: Alternative Sampling Strategies BACKGROUND: Tacrolimus is a narrow therapeutic index medication, which requires therapeutic drug monitoring to optimize dosing based on systemic exposure. MITRA microsampling offers a convenient, minimally invasive approach for the collection of capillary blood samples from a finger prick versus conventional venous blood sampling for quantitation of tacrolimus blood concentrations. However, the suitability of MITRA microsampling for the determination of tacrolimus concentrations requires assessment in clinical settings. METHODS: Paired venous (2 mL) and capillary (10 μL) blood samples were collected pre–tacrolimus dose and 1 and 3 hours postdose during routine outpatient visits from stable adult liver or kidney transplant patients receiving prolonged-release tacrolimus. Tacrolimus concentrations were determined by liquid chromatography–tandem mass spectrometry, and the concentrations obtained by the 2 sampling methods were compared by linear regression and Bland–Altman agreement analyses. RESULTS: Samples were available for 82 transplant recipients (kidney, n = 41; liver, n = 41). A high correlation was observed between tacrolimus concentrations in capillary and venous blood samples (Pearson correlation coefficient, 0.97; Lin concordance coefficient, 0.87; slope of the fitted line, >1.0). Tacrolimus concentrations in capillary samples were 22.5% higher on average than in the corresponding venous blood samples (95% limits of agreement, 0.5%–44.6%). Similar results were observed in both transplant subgroups. CONCLUSIONS: MITRA finger prick sampling provides a convenient alternative to venipuncture for therapeutic drug monitoring in transplant recipients maintained on prolonged-release tacrolimus. When using the finger prick MITRA method, the positive bias in tacrolimus concentrations observed with this technique, when compared with venipuncture, needs to be taken into consideration. Therapeutic Drug Monitoring 2021-06 2020-12-04 /pmc/articles/PMC8115740/ /pubmed/33278240 http://dx.doi.org/10.1097/FTD.0000000000000847 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Focus Series: Alternative Sampling Strategies
Undre, Nasrullah
Dawson, Ian
Aluvihare, Varuna
Kamar, Nassim
Saliba, Faouzi
Torpey, Nicholas
Anaokar, Swapneel
Kazeem, Gbenga
Hussain, Imran
Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
title Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
title_full Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
title_fullStr Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
title_full_unstemmed Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
title_short Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
title_sort validation of a capillary dry blood sample mitra-based assay for the quantitative determination of systemic tacrolimus concentrations in transplant recipients
topic Focus Series: Alternative Sampling Strategies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115740/
https://www.ncbi.nlm.nih.gov/pubmed/33278240
http://dx.doi.org/10.1097/FTD.0000000000000847
work_keys_str_mv AT undrenasrullah validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients
AT dawsonian validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients
AT aluviharevaruna validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients
AT kamarnassim validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients
AT salibafaouzi validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients
AT torpeynicholas validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients
AT anaokarswapneel validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients
AT kazeemgbenga validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients
AT hussainimran validationofacapillarydrybloodsamplemitrabasedassayforthequantitativedeterminationofsystemictacrolimusconcentrationsintransplantrecipients